Pericapsular Nerve Group Block in Shoulder Surgery
Postoperative Pain

About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring pericapsular nerve group block, postoperative pain, shoulder surgery
Eligibility Criteria
Inclusion Criteria:Patients scheduled for elective arthroscopic shoulder surgery under general anesthesia Patients aged 18 to 65 years American Society of Anesthesiologists (ASA) physical status value I-III patients - Exclusion Criteria: coagulopathy, neuropathy, use of anticoagulants, severe diabetes mellitus, local anesthetic and/or opioid allergy or sensitivity, a history of chronic pain, pre-existing psychiatric illness, can't understand pain scoring, Body mass index greater than 35 kg/m2, There is an infection in the body area to be blocked, Continuing follow-up and treatment in the intensive care unit, open shoulder surgery do not approve the informed consent form pregnant
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Pericapsular nerve group block (Group P)
control group (Group C)
Pericapsular nerve group block will be performed with 20 ml of 0.5% bupivacaine hydrochloride before general anesthesia is applied to the patients in Group P.
No block will be applied to patients in Group C.